Return to study ST000329 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
GlcCer(d14:1(4E)/20:0(2OH)) ME115847 GlcCer 14:1;O2(4E)/20:0;O 5.05750.5285Reversed phase NEGATIVE ION MODE
GlcCer (d38:1) ME115842 GlcCer 38:1;O2 6.457790.5969Reversed phase NEGATIVE ION MODE
GlcCer (d40:1) ME115843 GlcCer 40:1;O2 7.156818.628Reversed phase NEGATIVE ION MODE
GlcCer (d41:1) ME115844 GlcCer 41:1;O2 7.497832.6413Reversed phase NEGATIVE ION MODE
GlcCer (d42:1) ME115845 GlcCer 42:1;O2 7.822846.66Reversed phase NEGATIVE ION MODE
GlcCer (d42:2) ME115846 GlcCer 42:2;O2 7.138844.6453Reversed phase NEGATIVE ION MODE
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/... ME115623 LacCer 18:1;O2/16:0 4.874862.625Reversed phase POSITIVE ION MODE
GlcCer (d40:1) ME115624 GlcCer 40:1;O2 7.226806.648Reversed phase POSITIVE ION MODE
GlcCer (d42:1) ME115625 GlcCer 42:1;O2 7.876812.69747Reversed phase POSITIVE ION MODE
GlcCer (d42:2) ME115626 GlcCer 42:2;O2 7.272832.6636Reversed phase POSITIVE ION MODE
Lactosylceramide (d18:1/24:1(15Z)) ME115627 LacCer 18:1;O2/24:1 6.861972.7346Reversed phase POSITIVE ION MODE


  logo